Last reviewed · How we verify
Ethanol 98% Solution
At a glance
| Generic name | Ethanol 98% Solution |
|---|---|
| Sponsor | Orfagen |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers (NA)
- A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease (PHASE2)
- The Peregrine Study: A Safety and Performance Study of Renal Denervation (NA)
- Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ethanol 98% Solution CI brief — competitive landscape report
- Ethanol 98% Solution updates RSS · CI watch RSS
- Orfagen portfolio CI